Tennessee officials have filed a motion to prevent attorneys for Christa Pike from inspecting the lethal injection drug used in her botched execution, citing risks to the drug supplier’s identity. The state’s request follows a judge’s order to preserve all evidence related to the September 30 execution attempt.
State seeks to block drug inspection
In a Friday court filing, the Tennessee Department of Correction argued that allowing Pike’s legal team to examine or test leftover pentobarbital vials would reveal the supplier, violating state law. An unnamed department employee stated in an affidavit that even redacted labels could expose the vendor, noting that another supplier had ceased communications with the state in 2023 due to similar concerns.
Judge’s order and execution details
Chancellor I’Ashea L. Myles previously ordered the preservation of all physical evidence from the execution, including needles, drug vials, and residual pentobarbital. Pike, 50, survived two doses of pentobarbital, which her attorneys allege did not enter her bloodstream correctly and instead caused severe burns and blistering on her arms. The state has confirmed compliance with the judge’s broader preservation order.
Supplier secrecy and broader implications
The state’s motion highlights ongoing secrecy surrounding execution drugs, a practice states argue is necessary to protect suppliers from harassment or retaliation. An affidavit cited in the filing stated that vendors have grown “skittish,” with some threatening to cut ties if their identity is disclosed. The employee warned that losing the current supplier could halt executions in Tennessee, though no timeline or specific consequences were detailed.
Pike was convicted of the 1987 murder of 19-year-old Colleen Slemmer and was set to become the first woman executed in Tennessee in over two centuries. The failed execution attempt has prompted legal challenges and scrutiny of the state’s lethal injection protocols.